Immunomodulatory effect of different statin regimens on regulatory T-cells among patients with acute coronary syndrome: a systematic review and network meta-analysis of randomized clinical trials

Please use this identifier to cite or link to this item: https://essuir.sumdu.edu.ua/handle/123456789/89568

Or use following links to share this resource in social networks: Recommend this item

Title	Immunomodulatory effect of different statin regimens on regulatory T-cells among patients with acute coronary syndrome: a systematic review and network meta-analysis of randomized clinical trials
Authors	Greca, E. Kacimi, S. E. O. Ghozy, S. Wireko, A. A. Toufik, A. Poudel, S. Prendi, B. Michel, G. Michel, J.
ORCID
Keywords	patients acute coronary syndrome (ACS) statin therapy progression of atherosclerosis controlling the pathogenesis of ACS suppressor regulatory T cells (Tregs).
Type	Conference Papers
Date of Issue	2022
URI	https://essuir.sumdu.edu.ua/handle/123456789/89568
Publisher	Oxford University Press
License	Creative Commons Attribution 4.0 International License
Citation	E Greca, S E O Kacimi, S Ghozy, A A Wireko, A Toufik, S Poudel, B Prendi, G Michel, J Michel, Immunomodulatory effect of different statin regimens on regulatory T-cells among patients with acute coronary syndrome: a systematic review and network meta-analysis of randomized clinical trials, Cardiovascular Research, Volume 118, Issue Supplement_1, June 2022, cvac066.148, https://doi.org/10.1093/cvr/cvac066.148
Abstract	In patients with acute coronary syndrome (ACS), studies suggest that statin therapy, besides its role in reducing the progression of atherosclerosis through its pharmacological effect, plays a pivotal role in controlling the pathogenesis of ACS through the anti-inflammatory effects of suppressor regulatory T cells (Tregs).
Appears in Collections:	Наукові видання (НН МІ)